IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage biotechnology company developing Alzheimer’s disease therapeutics and AI-enabled healthcare technologies, disclosed in a Form 4 filing that two senior executives increased their ownership…